Abbott Laboratories (Pakistan) Limited Announces Board Meeting to Review Half-Yearly Accounts

Karachi: The Board of Directors of Abbott Laboratories (Pakistan) Limited will hold a virtual meeting on August 26th, 2024, to review the company’s financial performance for the first half of the year, which ended on June 30th, 2024. The meeting aims to consider the Half Yearly Accounts for the period.

According to information available from the Pakistan Stock Exchange (PSX), the company has instituted a “Close Period” from August 19th, 2024, to August 26th, 2024. This is in compliance with Clause 5.6.4 of the PSX Regulations, which restricts directors, the CEO, and executives from buying or selling company shares during this period. This measure ensures that all stakeholders maintain compliance with the regulatory framework intended to prevent insider trading.

The company has advised relevant Certificate Holders of the Exchange to note the trading restriction dates and the upcoming board meeting. This announcement is significant as it relates to the company’s compliance with stock exchange regulations and reflects its commitment to transparency in its financial disclosures.

The post Abbott Laboratories (Pakistan) Limited Announces Board Meeting to Review Half-Yearly Accounts appeared first on .